ETF Managers Group’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $150K | Buy |
+68,940
| New | +$150K | ﹤0.01% | 608 |
|
|
2022
Q4 | – | Sell |
-94,493
| Closed | -$612K | – | 647 |
|
|
2022
Q3 | $612K | Buy |
94,493
+7,128
| +8% | +$46.2K | 0.02% | 325 |
|
|
2022
Q2 | $393K | Buy |
87,365
+38,076
| +77% | +$171K | 0.01% | 553 |
|
|
2022
Q1 | $445K | Sell |
49,289
-3,864
| -7% | -$34.9K | 0.01% | 489 |
|
|
2021
Q4 | $729K | Buy |
53,153
+3,229
| +6% | +$44.3K | 0.01% | 415 |
|
|
2021
Q3 | $1.12M | Sell |
49,924
-3,440
| -6% | -$76.8K | 0.02% | 258 |
|
|
2021
Q2 | $714K | Buy |
+53,364
| New | +$714K | 0.01% | 324 |
|
|
2020
Q4 | – | Sell |
-98,486
| Closed | -$255K | – | 639 |
|
|
2020
Q3 | $255K | Buy |
98,486
+7,661
| +8% | +$19.8K | 0.01% | 545 |
|
|
2020
Q2 | $317K | Buy |
+90,825
| New | +$317K | 0.01% | 387 |
|
|
2018
Q2 | – | Sell |
-13,478
| Closed | -$86K | – | 567 |
|
|
2018
Q1 | $86K | Buy |
13,478
+2,244
| +20% | +$14.3K | 0.01% | 326 |
|
|
2017
Q4 | $102K | Buy |
11,234
+1,792
| +19% | +$16.3K | 0.01% | 239 |
|
|
2017
Q3 | $93K | Buy |
9,442
+604
| +7% | +$5.95K | 0.01% | 143 |
|
|
2017
Q2 | $69K | Buy |
+8,838
| New | +$69K | 0.01% | 213 |
|